Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-18-026146

Director sold 25,000 shares at $6.63 ($165,750)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GIVEN DOUGLAS B Director 2018-04-24 Sale −25,000 $6.63 $165,750 155,000 D
Open-market sales · 25,000 sh · avg $6.63 · $165,750
Loading xslF345X03/doc4.xml…